Assessment of Efficacy and Safety of Tislelizumab for Esophageal Squamous Cell Carcinoma. JMHRP [Internet]. 2025 Oct. 30 [cited 2026 Mar. 23];2(2):1-9. Available from: https://medical-health-psychiatry.com/1/article/view/64